首页> 美国卫生研究院文献>Translational Oncology >Gene expression profile identifies distinct molecular subtypes and potential therapeutic genes in Merkel cell carcinoma
【2h】

Gene expression profile identifies distinct molecular subtypes and potential therapeutic genes in Merkel cell carcinoma

机译:基因表达谱鉴定了Merkel细胞癌中的不同分子亚型和潜在治疗基因

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Merkel cell carcinoma (MCC) is a rare primary cutaneous neoplasm of neuroendocrine carcinoma of the skin. About 80% of the MCC occurs due to Merkel cell polyomavirus (MCPyV) and 20% of the tumors usually occur due to severe UV exposure which is a more aggressive type of MCC. It tends to have an increased incidence rate among elderly and immunosuppressed individuals. On therapeutic level, sub-classification of MCC through molecular subtyping has emerged as a promising technique for MCC prognosis. In current study, two consistent distinct molecular subtypes of MCCs were identified using gene expression profiling data. Subtypes I MCCs were associated with spliceosome, DNA replication and cellular pathways. On the other hand, genes overexpressed in subtype II were found active in TNF signalling pathway and MAPK signalling pathway. We proposed different therapeutic targets based on subtype specificity, such as , , in case of subtype I and , for subtype II. Such findings may provide fruitful knowledge to understand the intrinsic subtypes of MCCs and the pathways involved in distinct subtype oncogenesis, and will further advance the knowledge in developing a specific therapeutic strategy for these MCC subtypes.
机译:Merkel细胞癌(MCC)是一种罕见的皮肤神经内分泌癌的初级皮肤肿瘤。由于Merkel CelloMavirus(MCPyV)和20%的肿瘤通常由于严重的紫外线暴露而导致的MCC,20%的肿瘤发生了20%的MCC,这是一种更积极的MCC。它往往在老年人和免疫抑制的个体中产生增加的发病率。在治疗水平上,通过分子亚型的MCC亚分类作为MCC预后的有希望的技术。在目前的研究中,使用基因表达分析数据鉴定了两种一致的MCC分子亚型。亚型I MCC与缩写剂,DNA复制和细胞途径有关。另一方面,在TNF信号通路和MAPK信号通路中发现亚型II中过表达的基因。我们提出了基于亚型特异性的不同治疗靶标,例如,在亚型I和亚型II的情况下。这些发现可以提供富有成效的知识,以了解MCCs的内在亚型和所涉及的不同亚型脑发生中涉及的途径,并进一步推进在为这些MCC亚型开发特定治疗策略的知识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号